Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphism

被引:8
作者
Morichika, S
Shima, M
Kamisue, S
Tanaka, I
Imanaka, Y
Suzuki, H
Shibata, H
Pemberton, S
Gale, K
McVey, J
Tuddenham, EGD
Yoshioka, A
机构
[1] NARA MED UNIV,DEPT PAEDIAT,KASHIHARA,NARA 634,JAPAN
[2] ROYAL POSTGRAD MED SCH,MRC,CTR CLIN SCI,HAEMOSTASIS RES GRP,LONDON,ENGLAND
基金
英国医学研究理事会;
关键词
haemophilia A; factor VIII; cross-reacting material (CRM); single-strand conformation polymorphism (SSCP); factor VIII gene;
D O I
10.1046/j.1365-2141.1997.2963113.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Haemophilia A is the most common X-linked blood coagulation disorder; it is caused by deficiency of factor VIII activity (FVIII:C), Half of the affected patients do not have detectable levels of FVIII protein in their plasma, whereas about 5% have normal levels of the FVIII antigen (FVIII:Ag) (> 50 u/dl), and are called cross-reacting material (CRM) positive (CRM+ or A(+)). About 45% of patients have reduced levels of the FVIII:Ag (1-50 u/dl), classified as CRM reduced (CRMR or A(R)). We screened the FVIII gene of 13 Japanese patients (five CRM+ and eight CRMR) by single-strand conformation polymorphism, and identified 11 different mutations in 13 patients by analysing all 26 exons (Trp255Cys, Tyr473Cys, Gly479Arg, Arg531His, Thr667Arg, Arg1689Cys, Arg1941Gln, Arg2150His, Arg2159Cys, Thr2245Ala and Gly2285Val). Seven mutations were identified in the A domains (four in the A2 domain), All the mutations are point mutations resulting in missense codons. Four mutations (Trp255Cys, Tkr667Arg, Thr2245Ala and Gly2285Val) have not been described previously.
引用
收藏
页码:901 / 906
页数:6
相关论文
共 22 条
[1]   2 TYPES OF HAEMOPHILIA (A+ AND A-) - A STUDY OF 48 CASES [J].
DENSON, KWE ;
BIGGS, R ;
HADDON, ME ;
BORRETT, R ;
COBB, K .
BRITISH JOURNAL OF HAEMATOLOGY, 1969, 17 (02) :163-&
[2]  
FAY PJ, 1994, J BIOL CHEM, V269, P20522
[3]  
FOSTER PA, 1990, BLOOD, V75, P1999
[4]  
Hayashi K, 1991, PCR Methods Appl, V1, P34
[5]   RESIDUES 484-508 CONTAIN A MAJOR DETERMINANT OF THE INHIBITORY EPITOPE IN THE A2 DOMAIN OF HUMAN FACTOR-VIII [J].
HEALEY, JF ;
LUBIN, IM ;
NAKAI, H ;
SAENKO, EL ;
HOYER, LW ;
SCANDELLA, D ;
LOLLAR, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14505-14509
[6]   MOLECULAR CHARACTERIZATION OF MILD-TO-MODERATE HEMOPHILIA-A - DETECTION OF THE MUTATION IN 25 OF 29 PATIENTS BY DENATURING GRADIENT GEL-ELECTROPHORESIS [J].
HIGUCHI, M ;
ANTONARAKIS, SE ;
KASCH, L ;
OLDENBURG, J ;
ECONOMOUPETERSEN, E ;
OLEK, K ;
ARAI, M ;
INABA, H ;
KAZAZIAN, HH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8307-8311
[7]   IMMUNOLOGIC STUDIES OF ANTIHEMOPHILIC FACTOR (AHF FACTOR 8) - CROSS-REACTING MATERIAL IN A GENETIC VARIANT OF HEMOPHILIA A [J].
HOYER, LW ;
BRECKENRIDGE, RT .
BLOOD, 1968, 32 (06) :962-+
[8]   ABNORMAL FACTOR-VIII HIROSHIMA - DEFECT IN CRUCIAL PROTEOLYTIC CLEAVAGE BY THROMBIN AT ARG(1689) DETECTED BY A NOVEL ELISA [J].
KAMISUE, S ;
SHIMA, M ;
NISHIMURA, T ;
TANAKA, I ;
NAKAI, H ;
MORICHIKA, S ;
TAKATA, N ;
KURAMOTO, A ;
YOSHIOKA, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (01) :106-111
[9]  
LAZARCHICK J, 1978, J CLIN INVEST, V62, P1048, DOI 10.1172/JCI109209
[10]   The sequence Glu(1811)-Lys(1818) of human blood coagulation factor VIII comprises a binding site for activated factor IX [J].
Lenting, PJ ;
vandeLoo, JWHP ;
Donath, MJSH ;
vanMourik, JA ;
Mertens, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :1935-1940